Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...

Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarterPreliminary ending 2025 cash and cash ...

When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life.

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation ...

If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the initiation of treatment for this progressive, relentles ...

Niagen Bioscience continues to see improving demand for Tru Niagen, strengthening cash generation, and a debt-free balance ...

Migraines affect millions in the UK, yet are often misunderstood and underestimated. From throbbing pain and nausea to ...

Our Mirror Beauty Lead Zoe has made a promise to do her beauty treatments from home this January in a bid to save £715 with ...